NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
Existing Patients For Providers →
(855) 940-4867
At Greenbrook Mental Wellness, the commitment to patient care is deeply woven into the fabric of every center. For Kelly, a Senior Behavioral Health Technician at Greenbrook locations in Columbia, Annapolis, and Greenbelt, Greenbrook's mission is more than just a career—it’s a calling.
“I care a lot about people, and it comes naturally for me to take care of them,” Kelly shares. “Making sure everything is taken care of, that technicians feel safe and happy, and that patients feel the same way—that puts me at peace.”
Kelly began her career at Greenbrook Mental Wellness Centers as a SPRAVATO® Coordinator, managing initial consultations and navigating insurance processes for patients. While the role was crucial, she soon realized her true passion was in day-to-day patient care.
“Being a Behavioral Health Technician (BHT) means you get to witness a patient’s progress firsthand. You see their growth and help guide them through their journey,” Kelly explains.
One of the most rewarding aspects of Kelly’s work is observing gradual but significant changes in patients undergoing NeuroStar® Transcranial Magnetic Stimulation (TMS) and SPRAVATO® (esketamine) nasal spray treatment.
“TMS patients often don’t notice a difference right away. But then, one day, they mention they washed the dishes last night—after months of struggling to complete even small tasks. That’s when you realize the treatment is working,” she says.
For patients undergoing SPRAVATO®, the change can be more immediate. “I had a patient who, after the very first session, said, ‘I feel better already.’ By the end of her treatment regimen, she went from a PHQ-9 score of 21 or 22 to 0.”
Greenbrook’s Care Team takes pride in guiding patients through their treatment journey, offering both expertise and emotional support. Kelly assures nervous patients that they are in the best hands.
“All of the technicians and staff here are invested in your journey. We want you to get better. Even if the treatment doesn’t lead to full remission, we’ll create a plan to ensure you continue to improve.”
What makes Greenbrook different from other mental health centers? According to Kelly, specialization is the key.
“This is all we do— NeuroStar® TMS and SPRAVATO®. We’re dedicated to helping our patients find relief from their depression with these treatments. Because we focus solely on these therapies, our Care Team is highly skilled, constantly updated on the latest developments, and committed to providing the best care possible.”
Greenbrook Mental Wellness continues to be a place where patients feel seen, supported, and cared for. With professionals like Kelly leading the way, patients at Greenbrook can trust that they are receiving dedicated, compassionate care that prioritizes their mental wellness.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.